Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trialYuankai Shi, Zhiyue Rao, Jian Fang et al.|Nature Medicine|2025Cited by 30
P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLCC. Zhou, Chengping Hu, Lizhu Lin et al.|Journal of Thoracic Oncology|2021Cited by 7